Giovanni Romualdi

Dr. Giovanni Romualdi

Eye Clinic, Azienda Ospedaliero-Universitaria Careggi, Florence, Tuscany, Italy
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RMRita Mencucci
Rita Mencucci
Giovanni RomualdiGiovanni Romualdi
Giovanni Romualdi
Alberto CarnicciAlberto Carnicci
Alberto Carnicci
FPFabio Panini
Fabio Panini
MBMatilde Buzzi
Matilde Buzzi
Fabrizio GiansantiFabrizio Giansanti
Fabrizio Giansanti
Background/Objectives: The Tecnis Eyhance is an enhanced monofocal intraocular lens (IOL) designed to improve intermediate vision without compromising distance clarity or increasing the incidence of photic phenomena. Although short-term results have been encouraging, long-term data remain limited. This study presents the 5-year follow-up of a previously published 6-month clinical evaluation, aiming to assess the stability of visual, optical, and patient-reported outcomes over time. Methods: A single-center retrospective study of 18 patients (36 eyes) undergoing bilateral Tecnis Eyhance IOL implantation was conducted. The same cohort from the original 6-month study was re-evaluated after a mean follow-up of 5 years. Visual acuity (distance, intermediate, near), defocus curves, contrast sensitivity, optical quality, effective lens position (ELP), halo size, and patient-reported measures were assessed. Results: Visual acuity remained stable across all distances, with binocular uncorrected intermediate visual acuity (UIVA) ≤ 0.2 logMAR in all patients. No significant changes were observed in optical quality parameters or contrast sensitivity. ELP remained consistent over time (p = 0.298), and posterior capsule opacification (PCO) requiring Nd:YAG capsulotomy developed in 5% of the eyes. Halo size was mild, and subjective glare perception did not increase. Spectacle independence remained high for distance (100%) and intermediate (more than 75%) tasks. Conclusions: This 5-year follow-up study confirms the long-term stability and effectiveness of the Tecnis Eyhance IOL. These findings support its long-term use as a stable monofocal IOL with enhanced intermediate function.

9 February 2024 in Life
Verified
Journal Article
Open access
PDF file
RMRita Mencucci
Rita Mencucci
Giovanni RomualdiGiovanni Romualdi
Giovanni Romualdi
CVChiara De Vitto
Chiara De Vitto
MCMichela Cennamo
Michela Cennamo
Purpose: Descemet membrane endothelial keratoplasty (DMEK) is currently regarded as the most effective surgical procedure for addressing Fuchs Endothelial Corneal Dystrophy (FECD), frequently performed in conjunction with cataract surgery. In this retrospective study, we present a comparison of visual performance, clinical outcomes, and optical quality between two types of monofocal Intraocular Lenses (IOLs): one standard and one enhanced intermediate vision model, implanted in patients who underwent combined phacoemulsification and DMEK surgery. Methods: This single center comparative retrospective study was conducted at the Eye Clinic of the University of Florence (Italy) and included a total of 48 eyes of 48 patients affected by FECD and cataract. All patients underwent combined DMEK with phacoemulsification procedures. The patients’ data were analyzed and divided into two groups: one group (standard group) consisted of 24 eyes that underwent phaco-DMEK with implantation of a monofocal IOL, and the second group (enhanced monofocal group) included 24 eyes that underwent phaco-DMEK with implantation of an enhanced monofocal IOL. In both groups, the following monocular visual outcomes were evaluated 6 months after surgery: Uncorrected Distance Visual Acuity (UDVA) and Best-Corrected Distance Visual Acuity (BCDVA) at 4 mts; Uncorrected Intermediate Visual Acuity (UIVA), Distance-Corrected Intermediate Visual Acuity (DCIVA) at 66 cm; Uncorrected Near Visual Acuity (UNVA) and Best Corrected Near Visual Acuity (BCNVA). Monocular defocus curves were also assessed. Furthermore, optical quality in terms of Contrast Sensitivity (CS) in photopic conditions, Higher-Order Aberrations (HOAs) at a pupil size of 5 mm. Modulation Transfer Function (MTF), Objective Scatter Index (OSI), and Strehl ratio, were also analyzed. A Patient-Reported Spectacle Independence Questionnaire was revised to evaluate spectacle independence outcomes. Results: the two groups did not exhibit statistically significant differences in terms of UDVA, BCDVA, UNVA and BCNVA, photopic CS, HOAs, OSI, Strehl ratio, and MTF. However, in the phaco-DMEK enhanced monofocal IOL group, significantly better results were observed in terms of UIVA and DCIVA as well as a different defocus curve profile at 1.50 D, providing better defocus results at intermediate distance compared with the ZCB00 IOL. Conclusion: In our study, we found that enhanced monofocal lens performed favorable visual outcomes, even in cases of FECD, compared to standard monofocal IOLs. Comparable optical quality observed in the Eyhance group could allow surgeons to consider these lenses as a viable option for selected patients with FECD.

31 March 2025 in Journal of Optometry
Verified
Journal Article
Open access
FTFederico Tommasi
Federico Tommasi
AGAlessio Giorgetti
Alessio Giorgetti
CMCaterina Monnetti
Caterina Monnetti
LFLorenzo Fini
Lorenzo Fini
Giovanni RomualdiGiovanni Romualdi
Giovanni Romualdi
SCStefano Cavalieri
Stefano Cavalieri
This study presents a detailed optical characterization of three intraocular lenses (IOLs) comparing two so called "enhanced range of field", Evolux IOL and Tecnis Eyhance IOL and one so called "narrow range of field", a standard monofocal IOL Acrysof IQ. The measurements are performed using the PMTF optical bench, basing on the Modulation Transfer Function (MTF) to evaluate the optical performance of each lens. The MTFa, representing the area under the MTF curve, is utilized as a key and synthetic metric to quantify performance across different spatial frequencies, providing insights into the IOLs' behavior as defocus varies. The results highlight the strengths and the weaknesses of the IOLs, with the Evolux showing a broadest depth of focus. The USAF resolution target is used to qualitatively assess the image reproduction at far, intermediate, and near distances, offering a visual representation of the IOLs' capabilities. These findings provide valuable information for selecting IOLs based on patient-specific visual requirements in cataract and refractive surgery.

19 June 2025 in Life
Verified
Journal Article
Open access
PDF file
Giovanni RomualdiGiovanni Romualdi
Giovanni Romualdi
MBMatilde Buzzi
Matilde Buzzi
PRPier Giuseppe Ruggeri
Pier Giuseppe Ruggeri
FTFederico Tommasi
Federico Tommasi
AGAlessio Giorgetti
Alessio Giorgetti
RMRita Mencucci
Rita Mencucci
Purpose: A novel enhanced monofocal intraocular lens (IOL) has been developed to improve functional intermediate vision, maintaining a distance vision comparable to a standard monofocal lens and avoiding the drawbacks of multifocal IOLs. The aim of this study is to perform optical bench analysis and to evaluate refractive and visual outcomes and patient satisfaction. Methods: This prospective comparative single-center study was conducted in Careggi Hospital, University of Florence (Italy). We included 100 eyes from 50 patients who underwent bilateral cataract surgery. One group received the standard monofocal Tecnis GCB00 IOL, while the other group received the novel enhanced monofocal Evolux IOL. We evaluated binocular visual and refractive outcomes at 6 months after surgery. Binocular defocus curves and contrast sensitivity (CS) were also assessed. Optical quality was also analyzed in terms of higher-order aberrations (HOAs), modulation transfer function (MTF), objective scatter index (OSI), Strehl ratio, effective lens position (ELP), and halo analysis. A Patient-Reported Spectacle Independence Questionnaire (PRSIQ) was performed to assess spectacle independence outcomes. Finally, we analyzed the optical bench of both lenses. Results: All eyes implanted with Evolux achieved excellent distance vision, comparable to that achieved with GCB00. Evolux showed better intermediate and near vision, without any loss of visual quality, contrast sensitivity, or the presence of halos and photic phenomena. The optical bench analysis confirmed the different optical properties of the two lenses and supported the behavior obtained with the clinical defocus curve. Conclusions: These preliminary results show good refractive accuracy and visual outcomes for the enhanced monofocal IOL Evolux after cataract surgery. Further studies are needed to confirm our findings in terms of the number of patients and the period of follow-up.

2 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Giovanni RomualdiGiovanni Romualdi
Giovanni Romualdi
MBMatilde Buzzi
Matilde Buzzi
PRPier Giuseppe Ruggeri
Pier Giuseppe Ruggeri
FTFederico Tommasi
Federico Tommasi
AGAlessio Giorgetti
Alessio Giorgetti
RMRita Mencucci
Rita Mencucci
Purpose: A novel enhanced monofocal intraocular lens (IOL) has been developed to improve functional intermediate vision, maintaining a distance vision comparable to a standard monofocal lens and avoiding the drawbacks of multifocal IOLs. The aim of this study is to perform optical bench analysis and to evaluate refractive and visual outcomes and patient satisfaction. Methods: This prospective comparative single-center study was conducted in Careggi Hospital, University of Florence (Italy). We included 100 eyes from 50 patients, that underwent bilateral cataract surgery. One group was implanted with the standard monofocal IOL Tecnis GCB00 and the other group the novel enhanced monofocal lens Evolux. We evaluated monocular and binocular visual and refractive outcomes at 6 months after surgery. Binocular defocus curves and contrast sensitivity (CS) were also assessed. Optical quality was also analyzed, in terms of higher-order aberrations (HOAs), Modulation Transfer Function (MTF), Objective Scatter Index (OSI), Strehl-ratio, Effective Lens Position (ELP) and halo analysis. A Patient-Reported Spectacle Independence Questionnaire (PRSIQ) was performed to evaluate spectacle independence outcomes. Finally, we analyzed the optical bench of both lenses. Results: All eyes implanted with Evolux achieved excellent distance vision, comparable to those achieved with GCB00. Evolux showed better intermediate and near vision, without any loss of visual quality, contrast sensitivity, or the presence of halos and photic phenomena. The optical bench analysis confirmed the different optical properties of the two lenses and supported the behavior obtained with clinical defocus curve Conclusion: These preliminary results show good refractive accuracy and visual outcomes for the enhanced monofocal IOL Evolux after cataract surgery. Further studies need to confirm our findings in terms of number of patients and period of follow-up.